THE ALZHEIMER'S SOCIETY
Christmas is a time of giving and our clinic continues to support the Alzheimer’s Society. We have their iconic forget-me-not badges with a donation box in our reception for anyone wishing to help the charity. In Wales, over 41,603 people have dementia, but 19,183 have still not been diagnosed.
Extract from Alzheimer’s Society Newsletter November 2023
Donanemab latest
In July, the exciting full findings of the study that discovered donanemab showed that it can slow down how quickly memory and thinking problems get worse in early Alzheimer’s disease.
The study showed that donanemab works better the earlier it is given. It reduced the speed at which memory and thinking get worse by over 20% depending on the amount of changes in the participant’s brain that were associated with Alzheimer’s disease. It also led to a slowing in the decline of participants’ ability to carry out daily tasks, such as driving or doing hobbies, by 40%.
Dr Richard Oakley, our Associate Director of Research and Innovation, said: ‘Dementia is the biggest killer in the UK, and over 60% of people living with dementia are thought to have Alzheimer’s disease. This is truly a turning point in the fight against Alzheimer’s, and science is proving that it is possible to slow down the disease.
Treatments like donanemab are the first steps towards a future where Alzheimer’s disease could be considered a long-term condition alongside diabetes or asthma. People may have to live with it, but they could have treatments that allow them to effectively manage their symptoms and continue to live fulfilled lives.
‘Diagnosis will be key to accessing any new treatments. We can’t have a situation where treatments are approved for use in the UK but people aren’t diagnosed early or accurately enough to be eligible. We need early and accurate diagnoses available for everyone, and the NHS to be ready to role out treatments such as donanemab and lecanemab if and when they are approved in the UK.
‘We’re so proud that research funded by Alzheimer’s Society over 30 years ago led to the breakthroughs we’re seeing today, and the research our kind supporters are funding now will be pivotal in unlocking more breakthroughs’